Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Solid Organ Transplantation in Amyloidosis.
Theodorakakou F, Fotiou D, Dimopoulos MA, Kastritis E. Theodorakakou F, et al. Among authors: dimopoulos ma. Acta Haematol. 2020;143(4):352-364. doi: 10.1159/000508262. Epub 2020 Jun 12. Acta Haematol. 2020. PMID: 32535598 Free article. Review.
Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone.
Kastritis E, Anagnostopoulos A, Roussou M, Toumanidis S, Pamboukas C, Migkou M, Tassidou A, Xilouri I, Delibasi S, Psimenou E, Mellou S, Terpos E, Nanas J, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Haematologica. 2007 Oct;92(10):1351-8. doi: 10.3324/haematol.11325. Haematologica. 2007. PMID: 18024372 Free article. Clinical Trial.
Recent advances in the management of AL Amyloidosis.
Kastritis E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Br J Haematol. 2016 Jan;172(2):170-86. doi: 10.1111/bjh.13805. Epub 2015 Oct 22. Br J Haematol. 2016. PMID: 26491974 Free article. Review.
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone.
Kastritis E, Dialoupi I, Gavriatopoulou M, Roussou M, Kanellias N, Fotiou D, Ntanasis-Stathopoulos I, Papadopoulou E, Ziogas DC, Stamatelopoulos K, Manios E, Ntalianis A, Eleutherakis-Papaiakovou E, Papanikolaou A, Migkou M, Papanota AM, Gakiopoulou H, Psimenou E, Tselegkidi MI, Tsitsilonis O, Kostopoulos I, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Blood Adv. 2019 Oct 22;3(20):3002-3009. doi: 10.1182/bloodadvances.2019000147. Blood Adv. 2019. PMID: 31648323 Free PMC article.
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis.
Kastritis E, Fotiou D, Theodorakakou F, Dialoupi I, Migkou M, Roussou M, Karatrasoglou EA, Tselegkidi MI, Ntalianis A, Kanellias N, Eleutherakis-Papaiakovou E, Ntanasis-Stathopoulos I, Gakiopoulou C, Papanikolaou A, Papathoma A, Spyropoulou-Vlachou M, Psimenou E, Stamatelopoulos K, Gavriatopoulou M, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Amyloid. 2021 Mar;28(1):3-11. doi: 10.1080/13506129.2020.1798224. Epub 2020 Jul 27. Amyloid. 2021. PMID: 32713209
Next generation flow cytometry for MRD detection in patients with AL amyloidosis.
Kastritis E, Kostopoulos IV, Theodorakakou F, Fotiou D, Gavriatopoulou M, Migkou M, Tselegkidi MI, Roussou M, Papathoma A, Eleutherakis-Papaioakovou E, Dialoupi I, Kanellias N, Ntalianis A, Rousakis P, Trougakos IP, Tsitsilonis O, Gakiopoulou C, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Amyloid. 2021 Mar;28(1):19-23. doi: 10.1080/13506129.2020.1802713. Epub 2020 Aug 12. Amyloid. 2021. PMID: 32783569
Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease.
Kastritis E, Rousakis P, Kostopoulos IV, Gavriatopoulou M, Theodorakakou F, Fotiou D, Dialoupi I, Migkou M, Roussou M, Kanellias N, Tselegkidi MI, Eleutherakis-Papaiakovou E, Papanikolaou A, Gakiopoulou C, Psimenou E, Spyropoulou-Vlachou M, Gatou A, Terpos E, Tsitsilonis O, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Amyloid. 2021 Dec;28(4):259-266. doi: 10.1080/13506129.2021.1971192. Epub 2021 Sep 1. Amyloid. 2021. PMID: 34468250
Kinetics of anti-SARS-CoV-2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.
Kastritis E, Terpos E, Evangelakou Z, Theodorakakou F, Fotiou D, Manola MS, Gianniou DD, Bagratuni T, Kanellias N, Migkou M, Gavriatopoulou M, Trougakos IP, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Am J Hematol. 2022 Jan 1;97(1):E27-E31. doi: 10.1002/ajh.26406. Epub 2021 Nov 23. Am J Hematol. 2022. PMID: 34778995 Free PMC article. Clinical Trial. No abstract available.
1,275 results